1. Ajanta Pharma
stock logo

83% Buy

Ajanta Pharma Share Price

AJANTPHARM

₹2,085.40+₹6.55 (0.32%) Past YearLast updated on 19 Apr, 2024 | 03:46 PM IST
₹2,069.15₹2,107.95
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹26,176 Cr

Open

₹2,078.85

Close

₹2,078.85

Circuit range

₹2,494.60 - ₹1,663.10

Day range

₹2,069.15 - ₹2,107.95

Year range

₹1,246.75 - ₹2,353.95

Volume

34,465

Avg. traded

₹2,084.27

Revenue (12m)

₹4,036 Cr

Ajanta PharmaAjanta Pharma Limited is an India-based specialty pharmaceutical company. The Company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. The Company is engaged in the manufacturing and sale of branded generic and generic pharmaceutical products. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its branded generics business is spread across India, the rest of Asia, and Africa. Its business also consists of two verticals: United States generics and institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). The Company's cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin.

Read more

Ajanta Pharma Key indicators

arrow

52 week high

₹2,353.95

52 week low

₹1,246.75

P/E ratio

35.69

P/B ratio

7.09

ROE

17.42%

ROCE

21.98%

Dividend yield

0.34%

Debt/Equity ratio

EPS

44.38

Learn more

Investment checklist: (4/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

83%

Hold

9%

Sell

8%

This analysis is based on the reviews of 12 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

23.99%

Net profit margin

16.11%

ROE

17.42%

ROA

13.3%

ROCE

21.98%

Learn more

Ajanta Pharma Shareholder returns

arrow

1 day

+0.67%

1 week

-3.33%

1 month

-2.15%

3 months

-6.11%

1 year

+60.06%

3 years

+80.15%

5 years

+203.63%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Ajanta Pharma Share Price history

arrow
DayOpenCloseDay’s change
Thu, Apr 18 2024
₹2,064.40
₹2,078.85
+0.70%
Tue, Apr 16 2024
₹2,098.50
₹2,064.95
-1.62%
Mon, Apr 15 2024
₹2,112.10
₹2,117.75
+0.27%
Fri, Apr 12 2024
₹2,151.60
₹2,115.30
-1.72%
Wed, Apr 10 2024
₹2,150.65
₹2,139.65
-0.51%
Tue, Apr 9 2024
₹2,146.70
₹2,150.55
+0.18%
Mon, Apr 8 2024
₹2,187.80
₹2,135.50
-2.45%
Fri, Apr 5 2024
₹2,172.00
₹2,181.60
+0.44%

Shareholding info

arrow

Promoters (66.21%)

Mutual Funds (14.76%)

Retail and other (7.76%)

Foreign institutions-FII (8.54%)

Other domestic institutions (2.73%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹26/share

    Ex date 08 Feb 2024

    expand tab
  • Dividend • ₹10/share

    Ex date 04 Aug 2023

    expand tab
  • Dividend • ₹15/share

    Ex date 04 Aug 2023

    expand tab
  • Dividend • ₹7/share

    Ex date 11 Nov 2022

    expand tab
  • Bonus • 1:2

    Ex date 22 Jun 2022

    expand tab
  • Dividend • ₹9.5/share

    Ex date 09 Nov 2021

    expand tab

Learn more

Frequently asked questions